Psf3 as a possible biomarker of postoperative chemotherapy for patients with early pulmonary adenocarcinoma

BACKGROUND: Partner of Sld five 3 (Psf3) is a member of the heterotetrameric complex that consists of SLD5, Psf1, Psf2, and Psf3. We have shown in previous studies that high Psf3 expression was a poor prognostic marker for pulmonary adenocarcinoma. Here, we statistically evaluated the relationship b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Kenji, Tanaka, Yugo, Tauchi, Shunsuke, Kitamura, Yoshitaka, Nishio, Wataru, Sakai, Yasuhiro, Hayashi, Yoshitake, Yoshimura, Masahiro, Maniwa, Yoshimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885426/
https://www.ncbi.nlm.nih.gov/pubmed/31637868
http://dx.doi.org/10.1111/1759-7714.13230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885426/
https://www.ncbi.nlm.nih.gov/pubmed/31637868
http://dx.doi.org/10.1111/1759-7714.13230

Ejemplares similares